Bausch Health Companies denies bankruptcy rumors, despite a 44% stock drop.

Bausch Health Companies Inc, a global pharmaceutical firm, has denied rumors of potential bankruptcy or insolvency proceedings. The company, which has products in gastroenterology, hepatology, neurology, and eye health, among others, clarified that it has not been involved in bankruptcy discussions with creditors. Its stock value dropped 44% following a report of potential prepackaged Chapter 11 bankruptcy negotiations, but no final decision has been made.